JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Globus Medical Inc (Class A)

Fechado

SetorSaúde

95 0.62

Visão Geral

Variação de preço das ações

24h

Atual

Mín

92.84

Máximo

95.13

Indicadores-chave

By Trading Economics

Rendimento

22M

141M

Vendas

57M

826M

P/E

Médio do Setor

24.699

60.328

EPS

1.28

Margem de lucro

17.013

Funcionários

6,000

EBITDA

29M

244M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+18.56% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

481M

13B

Abertura anterior

94.38

Fecho anterior

95

Sentimento de Notícias

By Acuity

50%

50%

186 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Globus Medical Inc (Class A) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de abr. de 2026, 19:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Group Rejects EQT's Revised Offer

24 de abr. de 2026, 23:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Scoring the Cook Era -- Barrons.com

24 de abr. de 2026, 20:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

24 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:09 UTC

Ganhos

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 de abr. de 2026, 19:48 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 de abr. de 2026, 19:22 UTC

Ganhos

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 de abr. de 2026, 19:06 UTC

Ganhos

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 de abr. de 2026, 19:05 UTC

Conversa de Mercado

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 de abr. de 2026, 18:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 de abr. de 2026, 18:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Rejects Revised EQT Offer

24 de abr. de 2026, 18:12 UTC

Conversa de Mercado

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 de abr. de 2026, 18:06 UTC

Conversa de Mercado

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 de abr. de 2026, 17:42 UTC

Ganhos

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 de abr. de 2026, 17:28 UTC

Ganhos

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

24 de abr. de 2026, 17:28 UTC

Conversa de Mercado

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

24 de abr. de 2026, 17:12 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

24 de abr. de 2026, 17:11 UTC

Conversa de Mercado

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

24 de abr. de 2026, 17:09 UTC

Conversa de Mercado
Ganhos

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

24 de abr. de 2026, 17:09 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 17:06 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

24 de abr. de 2026, 16:51 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

24 de abr. de 2026, 16:20 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

24 de abr. de 2026, 16:20 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

24 de abr. de 2026, 16:20 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

24 de abr. de 2026, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

Comparação entre Pares

Variação de preço

Globus Medical Inc (Class A) Previsão

Preço-alvo

By TipRanks

18.56% parte superior

Previsão para 12 meses

Média 111.9 USD  18.56%

Máximo 123 USD

Mínimo 100 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para Globus Medical Inc (Class A) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

11 ratings

10

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

72.18 / 73.07Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

186 / 348 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat